WAM
ATHE

Wolverine Asset Management’s Alterity Therapeutics ATHE Stock Holding History

Wolverine Asset Management’s Portfolio ATHE Stock Details ATHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-65
Closed -$10K – 2323
2014
Q1 		$10K Buy
+65
New +$35.9K ﹤0.01% 1825

Other funds holding ATHE

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GBA
Garrison Bradford & Associates New York $88.4M AUM 15.86% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CAM
Columbia Asset Management Ann Arbor, Michigan $575M AUM 29.81% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Wolverine Asset Management's ATHE Position: Q2 2014 in Review

Wolverine Asset Management sold out of Alterity Therapeutics (ATHE) in Q2 2014, closing a stake of 65 shares — an estimated $10K sold.

Wolverine Asset Management first reported a position in ATHE in Q1 2014 and held it in 1 quarter. The position peaked at $10K in Q1 2014. 26 funds tracked by Wall St. Rank hold ATHE as of Q2 2014.

  • Wolverine Asset Management reported no remaining Alterity Therapeutics position as of Q2 2014 after selling out during the quarter.
  • Wolverine Asset Management sold 65 Alterity Therapeutics shares in Q2 2014, an estimated $10K.
  • Wolverine Asset Management first reported a position in Alterity Therapeutics in Q1 2014 and held it in 1 quarter.
  • Wolverine Asset Management's Alterity Therapeutics position peaked at $10K in Q1 2014.
  • 26 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q2 2014.

Based on Wolverine Asset Management's 13F filing for Q2 2014, filed 13 Aug 2014.